Early phase clinical trials to identify optimal dosing and safety

di Cook, Natalie, Hansen, Aaron R., Siu, Lillian L., Abdul Razak, Albiruni R.
Pubblicato in Mol Oncol (2014)

The Future of Clinical Trials Design in Oncology

di Spreafico, Anna, Hansen, Aaron R., Abdul Razak, Albiruni R., Bedard, Philippe L., Siu, Lillian L.
Pubblicato in Cancer Discov (2021)

Trabectedin for inoperable or recurrent soft tissue sarcoma in adult patients: a retrospective cohort study

di Angarita, Fernando A., Cannell, Amanda J., Abdul Razak, Albiruni R., Dickson, Brendan C., Blackstein, Martin E.
Pubblicato in BMC Cancer (2016)

Clinical outcomes of non‐osteogenic, non‐Ewing soft‐tissue sarcoma of bone––experience of the Toronto Sarcoma Program

di Veitch, Zachary W., Fasih, Samir, Griffin, Anthony M., Al‐Ezzi, Esmail M., Gupta, Abha A., Ferguson, Peter C., Wunder, Jay S., Abdul Razak, Albiruni R.
Pubblicato in Cancer Med (2020)

A phase II study of ENMD-2076 in advanced soft tissue sarcoma (STS)

di Veitch, Zachary, Zer, Alona, Loong, Herbert, Salah, Samer, Masood, Maryam, Gupta, Abha, Bradbury, Penelope A., Hogg, David, Wong, Andrew, Kandel, Rita, Charames, George S., Abdul Razak, Albiruni R.
Pubblicato in Sci Rep (2019)

Survival in Early Phase Immuno-Oncology Trials: Development and Validation of a Prognostic Index

di Day, Daphne, Guo, Christina, Kanjanapan, Yada, Tran, Ben, Spreafico, Anna, Joshua, Anthony M, Wang, Lisa, Abdul Razak, Albiruni R, Leighl, Natasha B, Hansen, Aaron R, Butler, Marcus O, Siu, Lillian L, Desai, Jayesh, Bedard, Philippe L
Pubblicato in JNCI Cancer Spectr (2019)

Switch Control Inhibition of KIT and PDGFRA in Patients With Advanced Gastrointestinal Stromal Tumor: A Phase I Study of Ripretinib

di Janku, Filip, Abdul Razak, Albiruni R., Chi, Ping, Heinrich, Michael C., von Mehren, Margaret, Jones, Robin L., Ganjoo, Kristen, Trent, Jonathan, Gelderblom, Hans, Somaiah, Neeta, Hu, Simin, Rosen, Oliver, Su, Ying, Ruiz-Soto, Rodrigo, Gordon, Michael, George, Suzanne
Pubblicato in J Clin Oncol (2020)

Cancer patients’ experiences with immune checkpoint modulators: A qualitative study

di Ala‐Leppilampi, Kari, Baker, Natalie A., McKillop, Chris, Butler, Marcus O., Siu, Lillian L., Spreafico, Anna, Abdul Razak, Albiruni R., Joshua, Anthony M., Hogg, David, Bedard, Philippe L., Leighl, Natasha, Oza, Amit M., Parsons, Janet A., Hansen, Aaron R.
Pubblicato in Cancer Med (2020)

Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma

di O’Neil, Bert H., Wallmark, John M., Lorente, David, Elez, Elena, Raimbourg, Judith, Gomez-Roca, Carlos, Ejadi, Samuel, Piha-Paul, Sarina A., Stein, Mark N., Abdul Razak, Albiruni R., Dotti, Katia, Santoro, Armando, Cohen, Roger B., Gould, Marlena, Saraf, Sanatan, Stein, Karen, Han, Sae-Won
Pubblicato in PLoS One (2017)

Phase I Study of BI 853520, an Inhibitor of Focal Adhesion Kinase, in Patients with Advanced or Metastatic Nonhematologic Malignancies

di de Jonge, Maja J. A., Steeghs, Neeltje, Lolkema, Martijn P., Hotte, Sebastien J., Hirte, Hal W., van der Biessen, Diane A. J., Abdul Razak, Albiruni R., De Vos, Filip Y. F. L., Verheijen, Remy B., Schnell, David, Pronk, Linda C., Jansen, Monique, Siu, Lillian L.
Pubblicato in Target Oncol (2019)

First-in-Class, First-in-Human Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Patients With Advanced Solid Tumors

di Abdul Razak, Albiruni R., Mau-Soerensen, Morten, Gabrail, Nashat Y., Gerecitano, John F., Shields, Anthony F., Unger, Thaddeus J., Saint-Martin, Jean R., Carlson, Robert, Landesman, Yosef, McCauley, Dilara, Rashal, Tami, Lassen, Ulrik, Kim, Richard, Stayner, Lee-Anne, Mirza, Mansoor R., Kauffman, Michael, Shacham, Sharon, Mahipal, Amit
Pubblicato in J Clin Oncol (2016)

Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas: The ANNOUNCE Randomized Clinical Trial

di Tap, William D., Wagner, Andrew J., Schöffski, Patrick, Martin-Broto, Javier, Krarup-Hansen, Anders, Ganjoo, Kristen N., Yen, Chueh-Chuan, Abdul Razak, Albiruni R., Spira, Alexander, Kawai, Akira, Le Cesne, Axel, Van Tine, Brian A., Naito, Yoichi, Park, Se Hoon, Fedenko, Alexander, Pápai, Zsuzsanna, Soldatenkova, Victoria, Shahir, Ashwin, Mo, Gary, Wright, Jennifer, Jones, Robin L.
Pubblicato in JAMA (2020)

Systemic and local immunity following adoptive transfer of NY-ESO-1 SPEAR T cells in synovial sarcoma

di Ramachandran, Indu, Lowther, Daniel E., Dryer-Minnerly, Rebecca, Wang, Ruoxi, Fayngerts, Svetlana, Nunez, Daniel, Betts, Gareth, Bath, Natalie, Tipping, Alex J., Melchiori, Luca, Navenot, Jean-Marc, Glod, John, Mackall, Crystal L., D’Angelo, Sandra P., Araujo, Dejka M., Chow, Warren A., Demetri, George D., Druta, Mihaela, Van Tine, Brian A., Grupp, Stephan A., Abdul Razak, Albiruni R., Wilky, Breelyn, Iyengar, Malini, Trivedi, Trupti, Winkle, Erin Van, Chagin, Karen, Amado, Rafael, Binder, Gwendolyn K., Basu, Samik
Pubblicato in J Immunother Cancer (2019)